News
Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19
Pfizer Inc. and BioNTech SE shared additional Phase 1 safety and immunogenicity data from their ongoing U.S. study of the BNT162 mRNA-based vaccine program against...
News
Bristol Myers Squibb Enters Agreement to Acquire Forbius, Adding Lead TGF-beta Asset to Portfolio
Bristol Myers Squibb and Forbius, a privately held, clinical-stage protein engineering company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases,...
Drug Research
Quanticate Announces new Partnership with Antev Ltd
Quanticate is pleased to partner with Antev Limited on a Phase II, Open-Label, Multicentre Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix Trifluoroacetate,...
News
UAEs Mubadala invests in US pharma business
Abu Dhabi’s sovereign wealth fund, Mubadala, and New York-based private equity group Kohlberg will take a majority stake in the pharmaceutical company PCI Pharma Services,...
News
Frontida BioPharma Completes Facility Expansion
Frontida BioPharm, Inc. announced the completion of a facility expansion to their oral solid dose manufacturing operations with the commissioning of a Highly Potent Compound...
News
Symbiosis confirms commitment to growth strategy with key appointment
Symbiosis Pharmaceutical Services (Symbiosis), a fast-growing contract manufacturing organisation (CMO) specialising in sterile manufacture of vaccines, pharmaceuticals and biopharmaceuticals, and headquartered in Stirling, UK, has...
News
Europital forecast 30% CAGR from UK biotech for three years
Europital – the global provider of medical management services for clinical research and drug development – announces it is opening a UK site to further...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.